Risk Modeling Helps Determine Care Pathway for Patient with Severe Mortality Risk

Ryan FoxUncategorized

Recently, a Hospital client in Wisconsin shared a story about how they used ePRISM and the personalized, informed consent documents from ePRISM to guide the delivery of care to one of their patients.  The patient in question was found unresponsive on the street and was rushed to the Emergency Room.  Upon arrival, the paramedics had revived the patient and the ER team determined he was experiencing acute myocardial infarction (heart attack) and would potentially benefit from percutaneous coronary intervention (PCI) to place stents in his arteries and improve the flow of blood.  In this patient’s case, they were rushed to the Cardiac Cath Lab for the procedure and the team ran the ePRISM risk assessments to determine his risk of poor outcomes.  Based on the evidence-based risk models, they determined this patients risk of mortality exceeded the potential benefit from the procedure (his mortality risk was greater than 50%!).  Using the personalized informed consent document, the Interventional Cardiologist consulted with the patient and his family, showed them the mortality risk and persuaded them to give the clinical team time to stabilize the patient before proceeding with PCI.  The patient and his family agreed to this care plan and a successful PCI was performed several days later after the patient’s mortality risk had decreased to a safe level.

This is just one example of how ePRISM is being used to improve the quality of care being delivered to patients on a daily basis and shows how important the delivery of personalized, precision medicine is in Cardiology.  We are thrilled to work so closely with each of our clients to achieve high levels of quality.